Posted in Web Novavax to submit 90.4% effective COVID-19 vaccine for FDA … January 16, 2022 Novavax’s COVID-19 vaccine candidate is 90.4 percent effective at preventing infection, according to a study published Dec. 15 in the New England Journal of Medicine. The drugmaker expects to … https://www.beckershospitalreview.com/pharmacy/novavax-to-submit-90-4-effective-covid-19-vaccine-for-fda-authorization-by-year-s-end.html